-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Leveraging and Enriching Social Media

Program: Special-Interest Sessions
Session: Training Program Directors Workshop
Friday, December 6, 2024, 9:00 AM-12:00 PM

Angela C Weyand, MD

Department of Pediatrics and Communicable Diseases, Division of Pediatric Hematology and Oncology, University of Michigan, Ann Arbor, MI

Disclosures: Weyand: Takeda: Consultancy, Honoraria, Research Funding; Pfizer: Research Funding; Biomarin: Honoraria; Novo Nordisk: Honoraria, Research Funding; Hemab: Consultancy; Bayer: Honoraria; Genentech: Honoraria; Sanofi: Consultancy, Honoraria, Research Funding; Octapharma: Honoraria.

See more of: Training Program Directors Workshop
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>